JP2019151627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019151627A5 JP2019151627A5 JP2019035140A JP2019035140A JP2019151627A5 JP 2019151627 A5 JP2019151627 A5 JP 2019151627A5 JP 2019035140 A JP2019035140 A JP 2019035140A JP 2019035140 A JP2019035140 A JP 2019035140A JP 2019151627 A5 JP2019151627 A5 JP 2019151627A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- diabetes
- acceptable salt
- compound according
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 206010012601 diabetes mellitus Diseases 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 108091006277 SLC5A1 Proteins 0.000 claims 2
- 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023000037A JP2023026566A (ja) | 2018-03-01 | 2023-01-04 | メチルラクタム環化合物及びその医薬用途 |
| JP2024214451A JP2025026615A (ja) | 2018-03-01 | 2024-12-09 | メチルラクタム環化合物及びその医薬用途 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018036307 | 2018-03-01 | ||
| JP2018036307 | 2018-03-01 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000037A Division JP2023026566A (ja) | 2018-03-01 | 2023-01-04 | メチルラクタム環化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019151627A JP2019151627A (ja) | 2019-09-12 |
| JP2019151627A5 true JP2019151627A5 (enExample) | 2022-03-07 |
| JP7206132B2 JP7206132B2 (ja) | 2023-01-17 |
Family
ID=67806229
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019035140A Active JP7206132B2 (ja) | 2018-03-01 | 2019-02-28 | メチルラクタム環化合物及びその医薬用途 |
| JP2023000037A Pending JP2023026566A (ja) | 2018-03-01 | 2023-01-04 | メチルラクタム環化合物及びその医薬用途 |
| JP2024214451A Pending JP2025026615A (ja) | 2018-03-01 | 2024-12-09 | メチルラクタム環化合物及びその医薬用途 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000037A Pending JP2023026566A (ja) | 2018-03-01 | 2023-01-04 | メチルラクタム環化合物及びその医薬用途 |
| JP2024214451A Pending JP2025026615A (ja) | 2018-03-01 | 2024-12-09 | メチルラクタム環化合物及びその医薬用途 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11014910B2 (enExample) |
| EP (1) | EP3760624A4 (enExample) |
| JP (3) | JP7206132B2 (enExample) |
| KR (1) | KR102795351B1 (enExample) |
| CN (1) | CN111757877B (enExample) |
| AR (1) | AR114418A1 (enExample) |
| AU (1) | AU2019227770B2 (enExample) |
| BR (1) | BR112020016788A2 (enExample) |
| CA (1) | CA3087859A1 (enExample) |
| CL (1) | CL2020002199A1 (enExample) |
| IL (1) | IL276311B2 (enExample) |
| MA (1) | MA52427A (enExample) |
| MX (1) | MX2020009070A (enExample) |
| MY (1) | MY205197A (enExample) |
| PE (1) | PE20210123A1 (enExample) |
| PH (1) | PH12020551340A1 (enExample) |
| SA (1) | SA520420037B1 (enExample) |
| SG (1) | SG11202007120UA (enExample) |
| TW (1) | TWI805699B (enExample) |
| WO (1) | WO2019168096A1 (enExample) |
| ZA (1) | ZA202004600B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| WO2019194207A1 (ja) | 2018-04-04 | 2019-10-10 | 日本たばこ産業株式会社 | ヘテロアリールで置換されたピラゾール化合物及びその医薬用途 |
| CN114585387B (zh) * | 2019-09-04 | 2024-10-29 | 日本烟草产业株式会社 | 利用联用药物的糖尿病的治疗或预防方法 |
| AU2021237149A1 (en) * | 2020-03-19 | 2022-10-06 | Japan Tobacco Inc. | Treatment or prevention method for chronic heart failure |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657282A (en) * | 1969-01-23 | 1972-04-18 | Merck & Co Inc | Carboxyepoxyethyl-1-phosphonic acid and derivatives |
| FR2665898B1 (fr) | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| JPH04247081A (ja) | 1991-02-01 | 1992-09-03 | Takeda Chem Ind Ltd | ５員複素環酸アミド類 |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| KR20050096956A (ko) | 2003-02-07 | 2005-10-06 | 다이이찌 세이야꾸 가부시기가이샤 | 피라졸 유도체 |
| AU2004200420A1 (en) | 2003-03-11 | 2004-09-30 | Astellas Pharma Inc. | Inhibitor of cyclooxygenase |
| JP2006182648A (ja) | 2003-04-08 | 2006-07-13 | Dai Ichi Seiyaku Co Ltd | ７員複素環誘導体 |
| US20050075375A1 (en) | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
| TW200526588A (en) | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| TW200526641A (en) | 2003-12-26 | 2005-08-16 | Daiichi Seiyaku Co | Amidopyrazole derivatives |
| CN1980665A (zh) | 2004-07-07 | 2007-06-13 | 默克公司 | 吡唑酰胺衍生物，包含这些化合物的组合物和使用方法 |
| CA2586358C (en) | 2004-11-16 | 2015-11-24 | Gw Pharma Limited | Use of tetrahydrocannabivarin (thcv) as neutral antagonist of the cb1 cannabinoid receptor |
| JP2008007405A (ja) | 2004-12-07 | 2008-01-17 | Takeda Chem Ind Ltd | カルボキサミド誘導体 |
| CN101243074A (zh) * | 2005-06-08 | 2008-08-13 | 日本烟草产业株式会社 | 杂环化合物 |
| CA2610172A1 (en) | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | Heterocyclic compound |
| JP4137956B2 (ja) * | 2005-06-08 | 2008-08-20 | 日本たばこ産業株式会社 | 複素環化合物 |
| WO2007034279A2 (en) * | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | C3a antagonists and pharmaceutical compositions thereof |
| EP1991528A2 (en) | 2006-01-18 | 2008-11-19 | Siena Biotech S.p.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| JP2009534439A (ja) | 2006-04-27 | 2009-09-24 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂｘカンナビノイド受容体モジュレータ及びカリウムチャンネルモジュレータを含む医薬組成物 |
| US20080027014A1 (en) | 2006-07-28 | 2008-01-31 | Tanabe Seiyaku Co., Ltd. | Novel SGLT inhibitors |
| WO2008061796A2 (en) | 2006-11-24 | 2008-05-29 | Ac Immune Sa | Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| MX2009005279A (es) | 2006-11-24 | 2009-05-28 | Ac Immune Sa | Derivados de n-(metil)-1h-pirazol-3-amina, n-(metil)-piridin-2-ami na y n-(metil)-tiazol-2-amina para el tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide, tal como por ejemplo alzheimer. |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| AU2008232419B2 (en) | 2007-04-02 | 2013-06-20 | Theracos, Inc. | Benzylic glycoside derivatives and methods of use |
| US20090181952A1 (en) | 2008-01-14 | 2009-07-16 | Wyeth | Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| JP5401544B2 (ja) | 2008-07-15 | 2014-01-29 | ノバルティス アーゲー | Ｄｇａｔ１阻害剤としてのヘテロアリール誘導体 |
| RU2639876C2 (ru) | 2010-03-30 | 2017-12-25 | Версеон Корпорейшн | Мультизамещенные ароматические соединения в качестве ингибиторов тромбина |
| AR087701A1 (es) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| WO2019194207A1 (ja) | 2018-04-04 | 2019-10-10 | 日本たばこ産業株式会社 | ヘテロアリールで置換されたピラゾール化合物及びその医薬用途 |
-
2019
- 2019-02-27 TW TW108106807A patent/TWI805699B/zh active
- 2019-02-28 MY MYPI2020003891A patent/MY205197A/en unknown
- 2019-02-28 MX MX2020009070A patent/MX2020009070A/es unknown
- 2019-02-28 IL IL276311A patent/IL276311B2/en unknown
- 2019-02-28 SG SG11202007120UA patent/SG11202007120UA/en unknown
- 2019-02-28 BR BR112020016788-6A patent/BR112020016788A2/pt unknown
- 2019-02-28 AR ARP190100503A patent/AR114418A1/es unknown
- 2019-02-28 MA MA052427A patent/MA52427A/fr unknown
- 2019-02-28 WO PCT/JP2019/007799 patent/WO2019168096A1/ja not_active Ceased
- 2019-02-28 CN CN201980016238.4A patent/CN111757877B/zh active Active
- 2019-02-28 US US16/289,500 patent/US11014910B2/en active Active
- 2019-02-28 PE PE2020001287A patent/PE20210123A1/es unknown
- 2019-02-28 KR KR1020207025856A patent/KR102795351B1/ko active Active
- 2019-02-28 CA CA3087859A patent/CA3087859A1/en active Pending
- 2019-02-28 AU AU2019227770A patent/AU2019227770B2/en active Active
- 2019-02-28 EP EP19760111.5A patent/EP3760624A4/en active Pending
- 2019-02-28 JP JP2019035140A patent/JP7206132B2/ja active Active
-
2020
- 2020-07-24 ZA ZA2020/04600A patent/ZA202004600B/en unknown
- 2020-08-24 SA SA520420037A patent/SA520420037B1/ar unknown
- 2020-08-26 CL CL2020002199A patent/CL2020002199A1/es unknown
- 2020-08-27 PH PH12020551340A patent/PH12020551340A1/en unknown
-
2021
- 2021-04-16 US US17/233,273 patent/US20220064148A1/en not_active Abandoned
-
2023
- 2023-01-04 JP JP2023000037A patent/JP2023026566A/ja active Pending
- 2023-06-28 US US18/343,415 patent/US20240174646A1/en not_active Abandoned
-
2024
- 2024-12-09 JP JP2024214451A patent/JP2025026615A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019048894A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| JP2019151627A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| FI3256218T3 (fi) | Kdm1a-estäjät sairauksien hoidossa | |
| JP2017524735A5 (enExample) | ||
| JP2016501221A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2015024998A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| RU2009126767A (ru) | Производное 1-фенил-1-тио-d-глюцитола | |
| JP2016518337A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2015155440A5 (enExample) | ||
| JP2017517565A5 (enExample) | ||
| JP2014530818A5 (enExample) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
| JP2015516427A5 (enExample) |